101 related articles for article (PubMed ID: 22105724)
1. Myocardial ischemia during endoscopic retrograde cholangiopancreatography - A real problem?
Vieira AM; Matias N; Cremers MI; Mangualde J; Freire R; Cortez J; Carradas C; Silvestre I; Oliveira AP
Minerva Gastroenterol Dietol; 2011 Dec; 57(4):361-7. PubMed ID: 22105724
[TBL] [Abstract][Full Text] [Related]
2. Silent myocardial ischaemia during endoscopic retrograde cholangiopancreatography.
Johnston SD; McKenna A; Tham TC
Endoscopy; 2003 Dec; 35(12):1039-42. PubMed ID: 14648418
[TBL] [Abstract][Full Text] [Related]
3. Myocardial ischemia during endoscopic retrograde cholangiopancreatography: an overlooked issue with significant clinical impact.
Lee CT; Lee TL; Liao WC; Chang CY; Tai CM; Chiang TH; Tu CH; Tseng WK; Lin JT
J Gastroenterol Hepatol; 2010 Sep; 25(9):1518-24. PubMed ID: 20796149
[TBL] [Abstract][Full Text] [Related]
4. ECG changes during endoscopic retrograde cholangio-pancreatography and coronary artery disease.
Christensen M; Milland T; Rasmussen V; Schulze S; Rosenberg J
Scand J Gastroenterol; 2005 Jun; 40(6):713-20. PubMed ID: 16036532
[TBL] [Abstract][Full Text] [Related]
5. Troponin T after endoscopic retrograde cholangiopancreatography: no evidence of harm.
Martin DF; Laasch HU; Kelly AM; Hammonds R; Wilbraham L; Sastry S; England A
Endoscopy; 2006 Aug; 38(8):793-6. PubMed ID: 17001569
[TBL] [Abstract][Full Text] [Related]
6. Safety of propofol in cirrhotic patients undergoing colonoscopy and endoscopic retrograde cholangiography: results of a prospective controlled study.
Fagà E; De Cento M; Giordanino C; Barletti C; Bruno M; Carucci P; De Angelis C; Venon WD; Musso A; Reggio D; Fagoonee S; Pellicano R; Ceretto S; Ciccone G; Rizzetto M; Saracco G
Eur J Gastroenterol Hepatol; 2012 Jan; 24(1):70-6. PubMed ID: 21941187
[TBL] [Abstract][Full Text] [Related]
7. [Sedation with propofol in endoscopic retrograde cholangiopancreatography: personal experience].
Zippi M; Traversa G; De Felici I; Febbraro I; Mattei E; Pietranico B; Sergio C; Sgarro MG; Occhigrosssi G
Clin Ter; 2008; 159(1):19-22. PubMed ID: 18399257
[TBL] [Abstract][Full Text] [Related]
8. Patient-reported outcome measures after endoscopic retrograde cholangiopancreatography: a prospective, multicentre study.
Glomsaker TB; Hoff G; Kvaløy JT; Søreide K; Aabakken L; Søreide JA;
Scand J Gastroenterol; 2013 Jul; 48(7):868-76. PubMed ID: 23721162
[TBL] [Abstract][Full Text] [Related]
9. Deep sedation for endoscopic retrograde cholangiopancreatography: intravenous propofol alone versus intravenous propofol with oral midazolam premedication.
Paspatis GA; Manolaraki MM; Vardas E; Theodoropoulou A; Chlouverakis G
Endoscopy; 2008 Apr; 40(4):308-13. PubMed ID: 18058653
[TBL] [Abstract][Full Text] [Related]
10. Cardiopulmonary complications of ERCP in older patients.
Fisher L; Fisher A; Thomson A
Gastrointest Endosc; 2006 Jun; 63(7):948-55. PubMed ID: 16733108
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of silent myocardial ischemia and arrhythmias in patients with coronary heart disease undergoing gastrointestinal tract endoscopic procedures.
Wilcox CM; Faibicher M; Wenger NK; Shalek KA
Arch Intern Med; 1993 Oct; 153(20):2325-30. PubMed ID: 8215735
[TBL] [Abstract][Full Text] [Related]
12. Incidence of sedation-related complications with propofol use during advanced endoscopic procedures.
Coté GA; Hovis RM; Ansstas MA; Waldbaum L; Azar RR; Early DS; Edmundowicz SA; Mullady DK; Jonnalagadda SS
Clin Gastroenterol Hepatol; 2010 Feb; 8(2):137-42. PubMed ID: 19607937
[TBL] [Abstract][Full Text] [Related]
13. The safety of deep sedation with propofol controlled by the endoscopist in endoscopic retrograde cholangiopancreatography (ERCP): a prospective study in a tertiary hospital.
Luzón Solanas L; Ollero Domenche L; Sierra Moros EM; Val Pérez J; Soria San Teodoro MT; Giménez Júlvez T; Uribarrena Amezaga R
Rev Esp Enferm Dig; 2018 Apr; 110(4):217-222. PubMed ID: 29421914
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic retrograde cholangiopancreatography with endoscopic sphincterotomy for symptomatic choledocholithiasis after recent myocardial infarction.
Cappell MS
Am J Gastroenterol; 1996 Sep; 91(9):1827-31. PubMed ID: 8792707
[TBL] [Abstract][Full Text] [Related]
15. [Metoprolol prevents myocardial ischemia during endoscopic retrograde cholangiopancreatography].
Rosenberg J; Overgaard H; Anderson MM; Rasmussen V; Schulze S
Ugeskr Laeger; 1997 Sep; 159(37):5514-8. PubMed ID: 9312920
[TBL] [Abstract][Full Text] [Related]
16. Improved sedation in diagnostic and therapeutic ERCP: propofol is an alternative to midazolam.
Jung M; Hofmann C; Kiesslich R; Brackertz A
Endoscopy; 2000 Mar; 32(3):233-8. PubMed ID: 10718389
[TBL] [Abstract][Full Text] [Related]
17. Myocardial ischemia, pancreatitis and ERCP.
Roberts-Thomson IC; Teo E; Roberts-Thomson KC
J Gastroenterol Hepatol; 2010 Sep; 25(9):1469-70. PubMed ID: 20796138
[No Abstract] [Full Text] [Related]
18. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
Christoforidis E; Goulimaris I; Kanellos I; Tsalis K; Demetriades C; Betsis D
Endoscopy; 2002 Apr; 34(4):286-92. PubMed ID: 11932783
[TBL] [Abstract][Full Text] [Related]
19. Factors that affect the variability in heart rate during endoscopic retrograde cholangiopancreatography.
Christensen M; Reinert R; Rasmussen V; Schulze S; Rosenberg J
Eur J Surg; 2002; 168(10):546-51. PubMed ID: 12666694
[TBL] [Abstract][Full Text] [Related]
20. Propofol versus midazolam for conscious sedation guided by processed EEG during endoscopic retrograde cholangiopancreatography: a prospective, randomized, double-blind study.
Krugliak P; Ziff B; Rusabrov Y; Rosenthal A; Fich A; Gurman GM
Endoscopy; 2000 Sep; 32(9):677-82. PubMed ID: 10989990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
